In a paper published in Cell, UNC School of Medicine researchers led by Bryan Roth, MD, PhD, show how to activate only one kind of brain receptor vital for pain relief. This receptor is not involved in addiction or respiratory depression that leads to death – the most severe side effects of opioid use.
For the first time, scientists at the University of North Carolina School of Medicine and collaborators solved the crystal structure of the activated kappa opioid receptor bound to a morphine derivative. They then created a new drug-like compound that activates only that receptor, a key step in the development of better pain medications.
The research, published in the journal Cell, shows a route toward creating opioids that relieve pain without causing the severe side effects at the heart of the opioid epidemic.
Currently, most opioids bind to several opioid receptors on the surface of cells, and this is one of the main reasons why opioids relieve severe pain but also trigger a wide range of side effects from nausea, numbness, and constipation to anxiety, severe dependency, hallucinations, and even death caused by respiratory depression.
“To create better opioids, we need to know the structure of their receptors,” said senior author Bryan Roth, MD, PhD, the Michael Hooker Distinguished Professor of Protein Therapeutics and Translational Proteomics in the Department of Pharmacology at UNC-Chapel Hill. “Until recently, this was impossible. But now we know the structure of the activated kappa opioid receptor. And we showed we can actually use the structure to make a drug-like compound with better properties than current opioids.”
The work was done in cell cultures in Roth’s lab, and in the future researchers will test this and related compounds in animal models. Also, using the detailed structure of the kappa opioid receptor (KOR), Roth’s lab and other scientists could develop other drug-like compounds highly selective for specific opioid receptors now that the structure is available.
“Tens of thousands people who take opioids die every year, and so we need safer and more effective drugs for treating pain and related conditions,” Roth said. “One of the big ideas is to target KORs because the few drugs that bind to it don’t lead to addiction or cause death due to overdose. Those side effects are mainly related to actions at the mu opioid receptor.”
Drugs that do hit KORs can have other side effects, such as hallucinations and dysphoria – a general state of unease or dissatisfaction with life related to anxiety and depression. This is why scientists need to know how this receptor is activated – to figure out the best way to bind a compound to KORs to only relieve pain.
Two postdoctoral fellows in Roth’s lab led the work – first author Tao Che, PhD, and corresponding author Daniel Wacker, PhD, who collaborated with several other scientists at UNC and around the world.
Receptors are proteins on the surface of cells. About 40 percent of drugs currently on the market target G-protein coupled receptors, or GPCRs, such as KORs. Typically, scientists have solved the chemical structure of proteins using a technique called x-ray crystallography. They first figure out the best way to force the protein to condense into a tightly packed crystal lattice, then shoot x-rays at the crystal, and finally calculate the protein’s structure based on how the x-ray beams change direction. But it’s very difficult to do this with opioid receptors because they are so small and delicate, and they do not sit still when bound to a ligand, or drug-like compound. And the exact moment a scientist would want to see the structure of the activated receptor is when it is bound to a compound that will then cause a biological effect, like a key opening a door.
To overcome this difficulty, Wacker, Che, and colleagues used Lipidic Cubic Phase crystallization – suspending KOR molecules in specially designed water-lipid mixtures and then slowly removing the water. Then, in order to be sure the receptors were sitting perfectly still, the researchers employed a variety of experimental tricks, including the use of a tiny antibody to “prop up” the receptor in its active state bound to a ligand – a derivative of morphine created by Sush Majumder, PhD, at Memorial Sloan Kettering Cancer Center. Che figured out this derivative called MP1104 would work after he screened dozens of similar candidates from the same class of drugs.
Once they had the crystal structure in hand, Che, Wacker and colleagues could see which parts of the receptor were important for binding to drug-like compounds. Collaborators at the University of Southern California led by Vsevolod Katritch, PhD, used computer models of ligands to see which parts they could chemically modify to make the ligands more likely to bind tightly to KORs but not to other receptors. With those modifications made, they synthesized a new compound and showed in lab tests that it is extremely selective for KORs.
“Now we have a much better understanding of the direction we have to explore in order to create a selective drug to activate only kappa opioid receptors,” Wacker said.
Che added, “It’s now possible to design new drugs based on the findings on this active KOR structure and tweak them to only have the desired pain relief effects.”
The Latest on: Opioids
- A drug dealer who gave a college student opioids to end her life was sentenced to 24 years on November 18, 2019 at 2:59 pm
Editor’s note: If you or someone you know needs help, call the National Suicide Prevention Lifeline at 800-273-TALK (8255). You can also text a crisis counselor by messaging the Crisis Text Line at ...
- Opioids only modestly improve pain relief, function in OA, not QoL on November 18, 2019 at 1:37 pm
ATLANTA — Among patients with osteoarthritis, opioids demonstrated only moderate benefit for pain and function, while contributing no notable benefit for quality of life or depression compared with ...
- Death of baby Maisie to overdose prompts calls for safer packaging of opioids on November 18, 2019 at 10:17 am
Death of baby Maisie to overdose prompts calls for safer packaging of opioids After an overdose death of a Brighton girl, Sen. Charles Schumer wants to see all types and doses of opiod-based drugs in ...
- Drug battle: New tech could help better identify dangerous trends involving opioids on November 18, 2019 at 9:48 am
In 2017 alone, opioids caused more than 1,000 deaths in our state. A new grant from the Centers for Disease Control and Prevention worth $5 million a year for three years, will allow the Georgia ...
- Advanced breast cancer patients denied access to life-prolonging drugs and opioids on November 18, 2019 at 5:52 am
The experts also called on policymakers worldwide to ensure that fears about the abuse of opioids should not limit cancer patients' access to adequate pain control. In the new guidelines ...
- U.S. Surgeon General Jerome Adams Speaks Today At Purdue About Opioids on November 18, 2019 at 4:48 am
State health officials say Indiana had 1,800 drug overdose deaths in 2017, with nearly two-thirds of those deaths involving opioids.
- Construction Workers Most Likely to Use Opioids and Cocaine, According to Recent Study on November 18, 2019 at 12:36 am
They were also asked about their use of opioids for non-medical reasons, like taking unprescribed opioids or taking them for the experience of getting high. The results showed that compared to ...
- In a single year, 14,000 kids were affected by NH's opioids disaster on November 17, 2019 at 6:58 pm
That year, 800 children were removed from their parents’ care because of opioids, and 1,500 children’s parents died or were imprisoned. That year, about 800 children and teenagers either accidentally ...
- Gov. Gretchen Whitmer, MDDHS, Michigan Opioids Task Force announce statewide efforts to combat opioid crisis on November 17, 2019 at 3:04 am
Governor Gretchen Whitmer, along with the Michigan Department of Health and Human Services (MDHHS) and other members of the Michigan Opioids Task Force, a coalition of state leaders tasked with ...
- Volusia-Flagler moms struggle to find assistance while recovering from opioids on November 16, 2019 at 10:01 am
The lack of services makes it more difficult for mothers to stay clean, resulting in a high number of babies born addicted to opioids. Volusia and Flagler counties reported three times as many ...
via Google News and Bing News